Pharma industry news : US CDMO Aldevron has revealed its plans to expand its antibody development facility in Freiburg, Germany. The Freiburg location of Aldevron is home to the GENOVAC antibody development platform, which became the second site for the US CDMO in 2004. According to Michael Chambers – Aldevron Founding partner and CEO, the […]
Continue reading …
Clinical trial news : Novus Therapeutics has initiated a phase 1 pharmacodynamics clinical trial of its lead candidate OP0201 for the treatment of otitis media, an infection that affects the middle ear. The California-based specialty pharma company, which is focused on developing drugs for ENT disorders, has dosed the first adult patients in the early-stage […]
Continue reading …
German pharma company Boehringer Ingelheim has exercised its option to acquire 100% of Austria-based oncolytic virus company ViraTherapeutics for €210 million in a move to develop next generation viral-based immuno-oncology therapies. In September 2016, Boehringer Ingelheim and ViraTherapeutics entered into a long term collaboration to develop the oncolytic virus therapy platform and also to investigate […]
Continue reading …Humira biosimilar Cyltezo meets objective in phase 3 plaque psoriasis trial
September 13, 2018 No Comment
German pharma company Boehringer Ingelheim said that Cyltezo, a biosimilar to AbbVie psoriasis drug Humira, achieved clinical equivalence to the reference product in a phase 3 trial in patients with moderate-to-severe chronic plaque psoriasis. Cyltezo succeeded in the NCT 02850965 phase 3 trial by not showing any clinically meaningful differences in efficacy, safety and immunogenicity […]
Continue reading …Novartis’ heart failure drug Entresto can be initiated early in hospitalized patients
August 26, 2018 No Comment
Swiss drugmaker Novartis unveiled new data on Entresto (sacubitril/valsartan) from a phase 4 study which confirms that the heart failure drug can be initiated early and safely across a broad range of heart failure patients with reduced ejection fraction (HFrEF), whose condition has been stabilized following hospitalization because of an acute heart failure episode. In […]
Continue reading …
BioNTech, a German biotechnology company, has joined forces with US pharma giant Pfizer to develop mRNA-based flu vaccines as part of a $425 million multi-year research and development (R&D) collaboration. As per the terms of the deal, BioNTech and Pfizer will jointly take up research and development activities for advancing mRNA-based vaccines to prevent influenza […]
Continue reading …
Dutch pharma company Norgine has opened new offices in its largest product sales market – Germany at Wettenberg as part of its continued investment to support its growth strategy. Norgine, which was established more than 110 years, acquires, develops, manufactures and commercializes products that address patients’ needs across specialist therapy areas. The areas of focus […]
Continue reading …Novartis to in-license atopic dermatitis drug MOR106 from MorphoSys, Galapagos
July 21, 2018 No Comment
Novartis has agreed to acquire the exclusive global development and marketing rights of atopic dermatitis drug MOR106 from MorphoSys and Galapagos in a deal that could go up to $1.1 billion. The Swiss drugmaker will make an upfront payment of €95 million ($111 million) to Galapagos and MorphoSys apart from potential milestone payments of up […]
Continue reading …Vyriad, Merck to launch phase 1 study of immuno oncology drugs Voyager-V1 and avelumab
July 18, 2018 No Comment
Vyriad, a US biotech company, has entered into a collaboration with Germany-based Merck to launch a phase 1 trial of their immuno oncology drugs combination of Voyager-V1 and Bavencio (avelumab), respectively, for metastatic colorectal cancer. According to Vyriad, Voyager-V1 is an oncolytic virotherapy which is a bullet-shaped, negative-sense RNA virus having low human seroprevalence. The […]
Continue reading …
Business News Today
- Chinese lifestyle product retailer MINISO opens new store in Madrid
- Unilever to acquire Los Angeles-based SmartyPants Vitamins
- Bega Cheese to acquire Lion Dairy & Drinks for $412m
- Nestlé to sell Yinlu peanut milk and canned rice porridge businesses in China
- TEXRail extension project : Trinity Metro selects AECOM as project consultant
- Castle Mountain Gold Mine California : Equinox Gold achieves commercial production
- McCormick to acquire Mexican hot sauce brand Cholula Hot Sauce
- Elliott Advisors offers to take over Swiss food company Aryzta for CHF0.8 per share
- US challenger bank Current raises $131m in Series C round
- HelloFresh to acquire US meal delivery service provider Factor75
